Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Young Donor Plasma Transfusions for PSP
NCT02460731Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2015
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fresh-frozen plasma in progressive supranuclear palsy (PSP), sponsored by University of California, San Francisco. Primary endpoint: Drug Limiting Toxicity at 6 months. Started May 2015; status: completed.
02
Drugs
fresh-frozen plasma
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT02460731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460731.